Parents' specific concerns about daily asthma medications for children

Journal of Asthma

Volumn 44, Issue 5, 2007, Pages 385-390

  Orrell Valente, Joan K ^a,d   Jarlsberg, Leah G ^a   Rait, Michelle A ^a   Thyne, Shannon M ^a   Rubash, Tabitha ^c   Cabana, Michael D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d Division of General Internal Medicine   (United States)

Author keywords

Asthma; Children; Daily controller medications; Medication concerns; Parents

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; LEUKOTRIENE RECEPTOR BLOCKING AGENT;

ARTICLE; ASTHMA; CARDIOVASCULAR EFFECT; CHILD; CHILD GROWTH; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG USE; FEMALE; GROWTH RETARDATION; HEART PALPITATION; HUMAN; HYPERACTIVITY; MAJOR CLINICAL STUDY; MALE; MOOD CHANGE; MOUTH CAVITY; PNEUMONIA;

ADRENAL CORTEX HORMONES; ASTHMA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; PARENTS; RANDOMIZED CONTROLLED TRIALS;

EID: 34347393675     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900701364221     Document Type: Article

References (17)

1. Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health, National Heart, Lung, Blood Institute, Expert Panel Report II. Public Health Service; 1997. NHLBI publication 97-4051.
2. Rand CS, Wise RA. Measuring adherence to asthma medication regimens. Am J Resp Crit Care Med 1994; 149:S69-76.
3. Blais L, Beauchesne MF, Levesque S. Socioeconomic status and medication prescription in pediatric asthma in Canada. J Adol Health 2006; 38:607.e9-607e16.
4. Yoos HL, Kitzman H, McMullen A. Barriers to anti-inflammatory medication use in childhood asthma. Ambul Pediatr 2003; 3:181-190.
5. Handelman L, Rich M, Bridgemohan CF, Schneider, L. Understanding pediatric inner-city asthma: an explanatory model approach. J Asthma 2004; 41:167-177.
6. Peterson-Sweeney K, McMullen A, Yoos HL, Kitzman H. Parental perceptions of their child's asthma: management and medication use. J Pediatr Health Care 2003; 17:118-125.
7. Conn KM, Halterman JS, Fisher SG, Yoos HL, Chin NP, Szilagyi PG. Parental beliefs about medications and medication adherence among urban children with asthma. Ambul Pediatri 2005; 5:306-310.
8. Conn KM, Halterman JS, Lynch K, Cabana MD. The impact of parents' medication beliefs on asthma management. Pediatrics. In press.
9. The 2004 United States Department of Health and Human Services Poverty Guidelines. Available at: 〈http://aspe.hhs.gov/poverty/04poverty. shtml〉. Accessed June 20, 2006.
10. Kim M, Klingle RS, Sharkey WF, Park HS, Smith DH, Cai D. A test of a cultural model of patients' motivation for verbal communication in patient-doctor interactions. Communication Monographs 2000; 67:262-283.
11. Longman J. Just following orders, doctors' orders.Available at: http://select. nytimes.com/search/restricted/article?res=F50812F638540C718EDDAD- 0894D9404482. Accessed October 6, 2006.
12. Pedersen S. Clinical safety of inhaled corticosteroids for asthma in children: an update of long-term trials. Drug Saf 2006; 29:599-612.
13. Slader CA, Reddel HK, Jenkins CR, Armour CL, Bosnic-Anticevich SZ. Complementary and alternative medicine use in asthma: who is using what? Respirology 2006; 11:373-387.
14. Alexander GC, Casalino LP, Meltzer DO. Patient-physician communication about out-of-pocket costs. JAMA 2003; 290:953-958.
15. Cabana MD, Slish KK, Evans D, et al. Impact of physician asthma care education on patient outcomes. Pediatrics 2006; 117: 2149-2157.
16. Alexander GC, Tseng CW. Six strategies to identify and assist patients burdened by out-of-pocket prescription costs. Cleve Clin J Med 2004; 71:433-437.
17. van Grunsven PM. The magnitude of fear of adverse effects as a reason for nonparticipation in drug treatment: a short review. J Asthma 2001; 38:113-119.